Skip to main content
Equibles

KILITCH · Kilitch Drugs (India) Limited · Financials

Use KILITCH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KILITCH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
215.40 INR +14.55 (+7.24%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 7624 Avg daily vol (3M) 6340

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
2.35B +18.7%
FY2026 Revenue FY2020–FY2026
Net Income
301.66M +13%
FY2026 Net Income FY2020–FY2026
Operating Cash Flow
239.58M +36.6%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
INR 2.39B 2.35B 1.98B 1.54B 1.4B 1.14B 685.23M 533.2M
INR 68.32M 36.23M 31.1M 33.5M 35.51M 24.66M 19.86M 19.99M
INR 51.54M 55.61M 50.41M 59.29M 49.19M 11.98M 7.54M 7.16M
INR 330.03M 386.54M 344.74M 193.55M 120.14M 96.14M 51.2M 16.07M
INR 104.25M 91.54M 95.34M 57.79M 37.32M 34.01M 13.53M 7.65M
INR 240.91M 301.66M 267.01M 146.01M 104.48M 73.67M 36.71M 8.42M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.